Core Viewpoint - The establishment of "analog planetary environments" teaching and training bases in China aims to enhance planetary science research and technology development for deep space exploration, particularly focusing on lunar and planetary environments [1][3]. Group 1: Teaching and Research Initiatives - Beijing University, in collaboration with several universities and research institutions, has created a "lunar underground space" teaching base at the volcanic lava tube in Jingpo Lake, Heilongjiang Province, to accumulate key technological reserves for deep space exploration [1]. - The teaching and research activities at the base emphasize the intersection of science and engineering, covering advanced fields such as geological exploration, underground structure CT imaging, embodied intelligent inspection, and digital twin technology [1]. Group 2: Technological Development - A team of 39 undergraduate students from Beijing University has developed a node-based seismometer and constructed a 3D model of the lava tube using seismic wave CT imaging technology [2]. - Two prototype robots, "Anteater" and "Salamander," have been developed for exploration in complex terrains, focusing on autonomous exploration and multifunctional operations [2]. Group 3: Future Plans and Goals - The "analog planetary environments" bases are expected to facilitate advancements in space mining and in-situ resource utilization technologies on the lunar surface [3]. - Future research will focus on lava tube exploration, digital twin modeling, planetary resource detection and development, and autonomous collaborative simulation training for robotic clusters, supporting manned lunar missions and the construction of international lunar research stations [3].

Company Overview - Lianjian (Jiangsu) Technology Co., Ltd. was established in 2003 and is located in Changzhou, primarily engaged in research and experimental development with a registered capital of 185.15934 million RMB [2] - Jiangsu Dongwei Sensing Technology Co., Ltd. was founded in 2020, also located in Changzhou, focusing on wholesale activities with a registered capital of 10 million RMB [2] Patent Application - Lianjian (Jiangsu) Technology Co., Ltd. and Jiangsu Dongwei Sensing Technology Co., Ltd. applied for a patent titled "A Welding Tool for Fine Metal Wires," published under CN120515917A, with an application date of June 2025 [1] - The patent describes a welding tool that includes a base plate with front and rear positioning components, designed for welding fine diameter metal wires with high processing precision and stable quality [1] Investment and Business Activities - Lianjian (Jiangsu) Technology Co., Ltd. has invested in 41 companies and participated in 3,333 bidding projects, holding 666 patent records and 11 trademark records, along with 72 administrative licenses [2] - Jiangsu Dongwei Sensing Technology Co., Ltd. has participated in 1 bidding project, holds 18 patent records, 4 trademark records, and has 6 administrative licenses [2]

来源：金融界 天眼查显示，近日，上海北稞生物科技有限公司成立，法定代表人为杨鹏涛，注册资本200万人民币， 上海正湛实业发展有限公司、素耳（河南）生物科技有限公司持股。 企业名称上海北稞生物科技有限公司法定代表人杨鹏涛注册资本200万人民币国标行业科学研究和技术 服务业>研究和试验发展>工程和技术研究和试验发展地址上海市浦东新区川沙路1098号8幢企业类型有 限责任公司(自然人投资或控股)营业期限2025-8-21至无固定期限登记机关浦东新区市场监督管理局 序号股东名称持股比例1上海正湛实业发展有限公司80%2素耳（河南）生物科技有限公司20% 经营范围含技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；人体干细胞技术开发和 应用；细胞技术研发和应用；医学研究和试验发展；货物进出口；技术进出口；进出口代理；住房租 赁；物业管理。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动） 自主展示（特色） 项目：工程和技术研究和试验发展；国内贸易代理；非居住房地产租赁；化妆品批发；化妆品零售。 ...

Company Formation - Hainan Yayan Biotechnology Co., Ltd. has been established with a registered capital of 43 million RMB [1] - The legal representative of the company is Chen Pengcheng, and it is wholly owned by Zhejiang Yayan Biotechnology Co., Ltd. [1] Business Scope - The company’s business scope includes technology import and export, general merchandise sales, and various types of medical equipment sales and leasing [1] - Specific activities include retail and wholesale of cosmetics, sales of chemical products (excluding licensed chemical products), and sales of household appliances [1] - The company is also involved in technical services, consulting, and enterprise management consulting [1] Company Registration Details - The company is registered in Haikou, Hainan Province, with a business duration until August 21, 2025, with no fixed term thereafter [1] - It is classified as a limited liability company (non-natural person investment or holding) [1]

Core Viewpoint - Recently, Gaomi Xingrui Medical Testing Laboratory Co., Ltd. was established with a registered capital of 18 million RMB, fully owned by Shandong Xingrui Biotechnology Co., Ltd. [1] Company Summary - Company Name: Gaomi Xingrui Medical Testing Laboratory Co., Ltd. [1] - Legal Representative: Wang Lixin [1] - Registered Capital: 18 million RMB [1] - Shareholder: Shandong Xingrui Biotechnology Co., Ltd. holds 100% [1] - Business Scope: Includes medical services, cell technology research and application, human stem cell technology development and application, and medical research and experimental development [1] - Business Type: Limited liability company (wholly owned by a legal entity) [1] - Registration Authority: Gaomi Market Supervision Administration [1] - Business Duration: Until August 21, 2025, with no fixed term thereafter [1] Industry Summary - Industry Standard: Scientific research and technical services, specifically research and experimental development, engineering and technical research and development [1] - Address: No. 5887, Lichuan Avenue (East), Xiazhuang Town, Gaomi City, Weifang, Shandong Province [1]

Group 1 - The core point of the article is that Huaborn Neutron Technology (Hangzhou) Co., Ltd. has recently completed a Pre-A round financing, raising several hundred million RMB, with investors including Hongcheng Investment, Kaitai Capital, Huzhou Industrial Group, Anfeng Venture Capital, and Caitong Capital [1] - Huaborn Neutron Technology was established in 2023 and is primarily engaged in research and experimental development, with a registered capital of 16.19 million RMB [1] - The company has made investments in five other enterprises and holds 69 trademark registrations and 106 patent registrations [1] Group 2 - The legal representative of Huaborn Neutron Technology is Wang Sheng, and the company is located in Hangzhou [1] - The shareholders of the company include Wang Sheng, Hangzhou Huaborn Enterprise Management Consulting Partnership, Jiaxing Noyou No.1 Equity Investment Partnership, Hangzhou Yuguang Medical Technology Partnership, and Hangzhou Kaitai Hongze Venture Capital Partnership [1]

Group 1 - The National Intellectual Property Administration has granted a patent for "a high toughness ultra-high performance concrete and its preparation method" to China Communications First Public Bureau Civil Engineering Research Institute Co., Ltd., China Communications First Public Bureau Group Co., Ltd., and China Communications Comprehensive Planning and Design Institute Co., Ltd. The patent announcement number is CN120097688B, with an application date of April 2025 [1] - China Communications First Public Bureau Civil Engineering Research Institute Co., Ltd. was established in 2014, located in Beijing, with a registered capital of 50 million RMB. The company has participated in 967 bidding projects and holds 62 patents [1] - China Communications First Public Bureau Group Co., Ltd. was established in 1987, also located in Beijing, with a registered capital of approximately 7630.9 million RMB. The company has invested in 337 enterprises and participated in 5000 bidding projects, holding 5000 patents [1] - China Communications Comprehensive Planning and Design Institute Co., Ltd. was established in 1985, located in Beijing, with a registered capital of 100 million RMB. The company has invested in 8 enterprises and participated in 1884 bidding projects, holding 75 patents [2]

Core Viewpoint - The company has approved the use of temporarily idle raised funds for cash management, ensuring that it does not affect the normal investment plans of the raised funds [1][5][8] Summary by Sections 1. Basic Situation of Raised Funds - The company issued 50 million shares at a price of 18.79 RMB per share, raising a total of 939.50 million RMB, with a net amount of 858.00 million RMB after deducting issuance costs [2][4] - The raised funds have been deposited in a special account approved by the board, and a tripartite supervision agreement has been signed with the sponsor and the bank [2][4] 2. Usage of Raised Funds - As of June 30, 2025, the company has used 477.18 million RMB of the raised funds, with 90.00 million RMB spent on cash management products [4][6] - The total interest generated from the raised funds in the bank amounts to 50.96 million RMB [4] 3. Cash Management Plan - The company plans to use up to 160 million RMB of temporarily idle raised funds for cash management within a 12-month period [5][7] - The investment products will include structured deposits, notice deposits, time deposits, large certificates of deposit, and agreed deposits, with a maximum term of twelve months [5][6] 4. Purpose and Benefits - The cash management aims to improve the efficiency of fund usage, reduce financial costs, and increase company revenue without affecting the investment projects [5][8] 5. Opinions from Supervisory Board and Sponsor - The supervisory board agrees with the cash management plan, stating it complies with relevant regulations and does not conflict with the investment projects [7][8] - The sponsor has confirmed that the necessary approval procedures have been followed and that the plan aligns with the interests of the company and its shareholders [8][9]

中信建投证券股份有限公司 关于中国电器科学研究院股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐机构"）为中 国电器科学研究院股份有限公司（以下简称"公司"、"中国电研"）首次公开发行 股票并在科创板上市的保荐机构及持续督导机构，根据《上海证券交易所科创板 股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》等法规的有关规定，对中国电研使用部分暂时闲置募集资金进行现金管理 事项进行了审慎核查，核查情况与意见如下： 一、募集资金基本情况 经上海证券交易所科创板股票上市委员会 2019 年 9 月 30 日审核同意，并经 中国证券监督管理委员会 2019 年 10 月 16 日《关于同意中国电器科学研究院股 份有限公司首次公开发行股票注册的批复》（证监许可[2019]1922 号）核准，同 意公司公开发行人民币普通股 5,000 万股，发行价格为 18.79 元/股，募集资金总 额 93,950 万元人民币，扣除发行费用（不含增值税）8,149.87 万元人民币，募集 资金净额为 85,800.13 万元人民币， ...

2024年1至12月份，百普赛斯的营业收入构成为：研究和试验发展占比98.13%，其他业务占比1.87%。 截至发稿，百普赛斯市值为97亿元。 每经AI快讯，百普赛斯（SZ 301080，收盘价：57.93元）8月21日晚间发布公告称，公司第二届第二十 次董事会会议于2025年8月20日在北京市北京经济技术开发区宏达北路8号公司会议室以通讯表决的方式 召开。会议审议了《关于公司<2025年半年度报告全文及其摘要>的议案》等文件。 （记者 张明双） 每经头条（nbdtoutiao）——核心产品净值仅剩7毛钱，昔日"公募一哥"任泽松怎么了？牛市踏空真相曝 光 ...